Assay Detects Genetic Anomalies and Helps Move Inquiries from Cause to Care Faster SANTA CLARA, Calif., September 13, 2017 Agilent Technologies Inc. (NYSE: A) has announced that it has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the GenetiSure Dx Postnatal Assay: its first comparative genomic hybridization (CGH) assay for diagnostic... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Premaitha Health plc in the High Court of Justice, Chancery Division, Patents Court in the United Kingdom. Illumina is seeking all available remedies, including damages and injunctive relief. The new suit accuses Premaitha’s IONA® Test of infringing... Read more
(Chelmsford, MA – Thursday, September 7, 2017) The new MiniLab EL Series from Spectro Scientific is a fast, convenient oil analysis tool for non-destructive testing of high performance engines in aircraft, racing cars, and railway environments. Oil analysis is a reliable and mature non-destructive testing technique that is widely used in engine design and development, production quality... Read more
Polarized light microscopes have been used in classical earth science studies for the last 100 years. Since then a lot of progress has been made to increase the user friendliness, ergonomy, and optical performance of such microscopes. Still, one thing has not changed: Classical polarized light (compound) microscopes can only be used for prepared samples,... Read more
Download PDF Read more
First FDA-Approved Cell Therapy for Leukemia Utilizes Thermo Fisher Scientific’s CTS Dynabeads Technology Kymriah™ (tisagenlecleucel, formerly CTL019), the first FDA-approved CAR-T cell therapy, uses CTS Dynabeads CD3/CD28 spherical beads to isolate, activate and expand T cells WALTHAM, Mass., Aug. 30, 2017 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved a new cell therapy... Read more
Basel, 30 August 2017 FDA approves Roche’s Actemra/RoActemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome Actemra/RoActemra is the first FDA-approved treatment for severe or life-threatening cytokine release syndrome induced by CAR T cell therapy CAR T cell therapy is an immunotherapy designed for the treatment of certain cancers This is the... Read more
Basel, 30 August 2017 FDA approves Roche’s Actemra/RoActemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome Actemra/RoActemra is the first FDA-approved treatment for severe or life-threatening cytokine release syndrome induced by CAR T cell therapy CAR T cell therapy is an immunotherapy designed for the treatment of certain cancers This is the... Read more
Energy dispersive X-ray fluorescence (ED-XRF) spectrometers can analyze the composition and concentration of elements contained in samples by detecting fluorescence X-rays generated from the surface of samples irradiated with X-rays. They can be used to easily and non-destructively analyze samples in a wide range of forms, including solids and powders. The EDX-7000 and EDX-8000 energy... Read more